dengue
Conditions
Interventions
control group:Symptomatic treatment
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients had met at least two criteria indicating probable dengue infection (on the basis of the 2014 National Health and Family Planning Commission of PRC dengue classifi cation scheme),and had a positive result on a dengue NS1 antigen or PCR assay. (2) Patients aged 18–65 years; (3) Patients had a fever (>38 degree C) for less than 48 h; (4) Patients agreed to participate in this research and sign the informed consent file.
Exclusion criteria
Exclusion criteria: (1) Patients with severe bleeding, including subcutaneous hematoma, hematemesis, melena, vaginal bleeding, hematuria, intracranial hemorrhage,etc; (2) Patients with dengue shock complication, Appeared heartbeat speed, acromegaly wet, capillary filling time prolonged > 3 seconds, pulse slim and fragile or undetectable, pulse pressure or the decrease of the blood pressure measurement,etc; (3) Patients with severe organ damage occurred: for wexample,liver damage (ALT and / or AST > 1000 IU/L), ARDS, acute myocarditis, acute renal failure, encephalopathy and encephalitis; (4) pregnant or nursing; (5) Patients with a history of allergies and Tanreqing allergy; (6) Patients who participated in the other clinical trials in the last 1 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of fever;Wihte blood cell count; | — |
Secondary
| Measure | Time frame |
|---|---|
| the rate of main symptoms disappeared;Platelet count; | — |
Countries
China
Contacts
Public ContactLi jun
Outcome results
None listed